Lilly completes Acquisition of ImClone Systems
Eli Lilly and Company today announced that it has completed its acquisition of ImClone Systems Incorporated.
Bristol-Myers Squibb Co. believes it has made a ``full and fair offer'' to acquire full ownership of ImClone Systems Inc., a spokeswoman said Monday in response to ImClone's statement that the bid undervalues ImClone.